| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Purpose: Loss of intercellular adhesion and increased cell motility promote tumor cell invasion. In the present study, E- and N-cadherin, members of the classical cadherin family, are investigated as inducers of epithelial-to-mesenchymal transition (EMT) that is thought to play a fundamental role during the early steps of invasion and metastasis of carcinomas. Cell growth factors are known to regulate cell adhesion molecules. The purpose of the study presented here was to investigate whether a gain in N-cadherin in pancreatic cancer is involved in the process of metastasis via EMT and whether its expression is affected by growth factors.
Experimental Design: We immunohistochemically examined the expression of N- and E-cadherins and vimentin, a mesenchymal marker, in pancreatic primary and metastatic tumors. Correlations among the expressions of N-cadherin, transforming growth factor (TGF)ß, and fibroblast growth factor 2 was evaluated in both tumors, and the induction of cadherin and vimentin by growth factors was examined in cultured cell lines.
Results: N-cadherin expression was observed in 13 of 30 primary tumors and in 8 of 15 metastatic tumors. N-cadherin expression correlated with neural invasion (P = 0.008), histological type (P = 0.043), fibroblast growth factor expression in primary tumors (P = 0.007), and TGF expression (P = 0.004) and vimentin (P = 0.01) in metastatic tumors. Vimentin, a mesenchymal marker, was observed in a few cancer cells of primary tumor but was substantially expressed in liver metastasis. TGF stimulated N-cadherin and vimentin protein expression and decreased E-cadherin expression of Panc-1 cells with morphological change.
Conclusion: This study provided the morphological evidence of EMT in pancreatic carcinoma and revealed that overexpression of N-cadherin is involved in EMT and is affected by growth factors.
This article has been cited by other articles:
|
|
 |
|
  M. J. Wheelock, Y. Shintani, M. Maeda, Y. Fukumoto, and K. R. Johnson Cadherin switching J. Cell Sci., March 15, 2008; 121(6): 727 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Javle, J. F. Gibbs, K. K. Iwata, Y. Pak, P. Rutledge, J. Yu, J. D. Black, D. Tan, and T. Khoury Epithelial-Mesenchymal Transition (EMT) and Activated Extracellular Signal-regulated Kinase (p-Erk) in Surgically Resected Pancreatic Cancer Ann. Surg. Oncol., December 1, 2007; 14(12): 3527 - 3533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hotz, M. Arndt, S. Dullat, S. Bhargava, H.-J. Buhr, and H. G. Hotz Epithelial to Mesenchymal Transition: Expression of the Regulators Snail, Slug, and Twist in Pancreatic Cancer Clin. Cancer Res., August 15, 2007; 13(16): 4769 - 4776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Gu, L. F. Zerbini, H. H. Otu, M. Bhasin, Q. Yang, M. G. Joseph, F. Grall, T. Onatunde, R. G. Correa, and T. A. Libermann Reduced PDEF Expression Increases Invasion and Expression of Mesenchymal Genes in Prostate Cancer Cells Cancer Res., May 1, 2007; 67(9): 4219 - 4226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Baumgart, M. S. Cohen, B. S. Neto, M. A. Jacobs, C. Wotkowicz, K. M. Rieger-Christ, A. Biolo, R. Zeheb, M. Loda, J. A. Libertino, et al. Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors Clin. Cancer Res., March 15, 2007; 13(6): 1685 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takano, F. Kanai, A. Jazag, H. Ijichi, J. Yao, H. Ogawa, N. Enomoto, M. Omata, and A. Nakao Smad4 is Essential for Down-regulation of E-cadherin Induced by TGF-{beta} in Pancreatic Cancer Cell Line PANC-1 J. Biochem., March 1, 2007; 141(3): 345 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shintani, M. A. Hollingsworth, M. J. Wheelock, and K. R. Johnson Collagen I Promotes Metastasis in Pancreatic Cancer by Activating c-Jun NH2-Terminal Kinase 1 and Up-regulating N-Cadherin Expression Cancer Res., December 15, 2006; 66(24): 11745 - 11753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Riou, R. Saffroy, C. Chenailler, B. Franc, C. Gentile, E. Rubinstein, T. Resink, B. Debuire, D. Piatier-Tonneau, and A. Lemoine Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma FASEB J, November 1, 2006; 20(13): 2291 - 2301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oltean, B. S. Sorg, T. Albrecht, V. I. Bonano, R. M. Brazas, M. W. Dewhirst, and M. A. Garcia-Blanco Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity PNAS, September 19, 2006; 103(38): 14116 - 14121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Lascombe, A. Clairotte, S. Fauconnet, S. Bernardini, H. Wallerand, B. Kantelip, and H. Bittard N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin. Cancer Res., May 1, 2006; 12(9): 2780 - 2787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Azuma, S. Ehata, H. Miyazaki, T. Watabe, O. Maruyama, T. Imamura, T. Sakamoto, S. Kiyama, Y. Kiyama, T. Ubai, et al. Effect of Smad7 Expression on Metastasis of Mouse Mammary Carcinoma JygMC(A) Cells J Natl Cancer Inst, December 7, 2005; 97(23): 1734 - 1746. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
